FDA Adverse Event Death Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1904233 · Received November 12, 2010

Report

Report Number
2024168-2010-02432
Event Type
Death
Date Received
November 12, 2010
Date of Event
September 10, 2010
Report Date
October 20, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. DEATH IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. REPORTEDLY, DIRECT STENTING WAS PERFORMED. IT SHOULD BE NOTED THAT THE IFU CAUTIONS THAT THE VESSEL SHOULD BE PRE-DILATED WITH AN APPROPRIATE SIZED BALLOON. FAILURE TO DO SO MAY INCREASE THE DIFFICULTY OF STENT PLACEMENT AND CAUSE PROCEDURAL COMPLICATIONS.

Description of Event or Problem · 1

IT WAS REPORTED VIA TRIAL THAT APPROXIMATELY 2 YEARS POST DIRECT STENTING OF TWO XIENCE STENTS, ONE IN THE PROXIMAL 1ST OBTUSE MARGINAL ARTERY (P 1STOM), AND ON IN THE MID RIGHT CORONARY ARTERY (MRCA), THE PATIENT DIED. THE PATIENT WAS BEING CONTACTED FOR THEIR 2 YEAR FOLLOW UP. PER A FAMILY MEMBER, THE PATIENT DID IN THEIR SLEEP. CAUSE OF DEATH IS UNK. ALTHOUGH REQUESTED THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8061161

Patients

Seq Age Sex Outcome Treatment
1 58 YR Death ASPIRIN| SERIAL #(B)(4))| STENT: XIENCE V ((B)(4), LOT #7110561,| OTHER: CLOPIDOGREL,